Andreas Seidl - Publications

Identification of relevant analytical methods for adeno-associated virus stability assessment during formulation development.

Journal: Microbiology spectrum

Published: June 30, 2025

An exploratory study on the effect of mechanical stress on particle formation in monoclonal antibody infusions.

Journal: Archiv der Pharmazie

Published: February 28, 2023

Autophosphorylation activates c-Src kinase through global structural rearrangements.

Journal: The Journal of biological chemistry

Published: February 28, 2019

N-glycans of complex glycosylated biopharmaceuticals and their impact on protein clearance.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: September 18, 2018

Comparative functional and pharmacological characterization of Sandoz proposed biosimilar adalimumab (GP2017): rationale for extrapolation across indications.

Journal: Expert opinion on biological therapy

Published: July 03, 2018

Rational Selection, Criticality Assessment, and Tiering of Quality Attributes and Test Methods for Analytical Similarity Evaluation of Biosimilars.

Journal: The AAPS journal

Published: February 13, 2018

Development and 10-year history of a biosimilar: the example of Binocrit®.

Journal: Therapeutic advances in medical oncology

Published: January 08, 2018

Maintaining consistent quality and clinical performance of biopharmaceuticals.

Journal: Expert opinion on biological therapy

Published: December 30, 2017

The structure-function relationship of disulfide bonds in etanercept.

Journal: Scientific reports

Published: January 16, 2017

T-cell assays confirm immunogenicity of tungsten-induced erythropoietin aggregates associated with pure red cell aplasia.

Journal: Blood advances

Published: October 03, 2016

Characterization and non-clinical assessment of the proposed etanercept biosimilar GP2015 with originator etanercept (Enbrel(®)).

Journal: Expert opinion on biological therapy

Published: July 28, 2016

Identification of Low-Level Product-Related Variants in Filgrastim Products Presently Available in Highly Regulated Markets.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Published: March 31, 2016